Essex Woodlands Management as of March 31, 2020
Portfolio Holdings for Essex Woodlands Management
Essex Woodlands Management holds 8 positions in its portfolio as reported in the March 2020 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Revance Therapeutics | 31.8 | $50M | 3.3M | 14.80 | |
| Eyepoint Pharmaceuticals | 27.5 | $43M | 42M | 1.02 | |
| Axogen (AXGN) | 16.3 | $25M | 2.4M | 10.40 | |
| Venus Concept | 16.0 | $25M | 7.0M | 3.55 | |
| Tela Bio (TELA) | 5.4 | $8.4M | 1.1M | 7.82 | |
| MediciNova (MNOV) | 2.6 | $4.1M | 1.1M | 3.72 | |
| Catalyst Biosciences | 0.2 | $344k | 79k | 4.38 | |
| Endologix | 0.1 | $89k | 126k | 0.71 |
